Crossmark

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency

Crossref DOI link: https://doi.org/10.1186/s13023-025-03592-9

Published Online: 2025-02-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seçinti, Ekin

Schantz, Karolina https://orcid.org/0000-0002-5466-0536
Delbecque, Laure

Krege, John

Mangrum, Rikki

Curtis, Sarah E.
License Information

Text and Data Mining valid from 2025-02-22

Version of Record valid from 2025-02-22
More Information

Article History

Received: 17 October 2024

Accepted: 2 February 2025

First Online: 22 February 2025

Declarations

:

: Not applicable to this review study.

: Not applicable (no individual data included).

: RM and KS report no competing interests. LD, ES, SC and JK are employees and shareholders of Eli Lilly and Company.

Document is current

Any future updates will be listed below